Table 1 Clinical and biochemical traits of the study subjects.
From: Inflammatory protein signatures in individuals with obesity and metabolic syndrome
Feature | OBO (n = 27) | OBM (n = 21) | P Value |
|---|---|---|---|
Age (years) | 36.82 ± 5.50 | 42.76 ± 6.89 | 0.080 |
Gender | 17(F) 10 (M) | 7(F) 14(M) | 0.0038 |
Height (cm) | 161.7 ± 7.9 | 164.9 ± 3.5 | 0.748 |
Weight (kg) | 115.7 ± 21.5 | 103.8 ± 33.1 | 0.161 |
BMI (kg/m2) | 41.2 ± 4.9 | 38.5 ± 2.8 | 0.228 |
HbA1c (mmol/mol) | 36.1 ± 4.01 | 58.5 ± 20 | 0.000 |
Triglycerides (mmol/L) | 1.19 ± 0.45 | 2.43 ± 1.52 | 0.001 |
Total cholesterol (mmol/L) | 4.6 ± 1.0 | 4.3 ± 1.2 | 0.328 |
Low-density lipoprotein (LDL)-Cholesterol (mmol/L) | 2.7 ± 1.0 | 2.2 ± 1.1 | 0.973 |
High-density lipoprotein (HDL)-cholesterol (mmol/L) | 1.4 ± 0.5 | 1.0 ± 0.2 | 0.004 |
Glucose (mmol/L) | 5.2 ± 0.6 | 7.6 ± 3.3 | 0.004 |
Creatinine (mmol/L) | 65.8 ± 14.1 | 77.8 ± 33.4 | 0.131 |
Insulin (miU/mL) | 18.9 ± 14.2 | 25.7 ± 15.3 | 0.19 |
C-reactive protein (CRP) (mg/L) | 9.09 ± 5.2 | 6.7 ± 3.9 | 0.086 |
Alanine aminotransferase (ALT) (U/L) | 26.8 ± 18.4 | 31.1 ± 15.9 | 0.394 |
Aspartate aminotransferase (AST) (U/L) | 20.5 ± 9.3 | 21.6 ± 6.4 | 0.632 |
